xIPOmeter
BillionToOne
BillionToOne focuses on innovative molecular diagnostics, utilizing their proprietary QCT technology to detect and measure DNA fragments at a single base-pair level. Their key products include the UNITY Screen, a non-invasive prenatal test that identifies fetal risk for aneuploidies and recessive conditions from a maternal blood sample, and the Northstar liquid biopsy assays, which aid in cancer therapy selection and monitoring by analyzing tumor DNA. Their mission is to enhance healthcare accessibility and precision through cutting-edge molecular testing techniques.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
Company valuation calculator
To calculate, specify one of the parameters
News related to BillionToOne8
BillionToOneBillionToOne's UNITY Fetal Antigen NIPT Transforms Care in ...
PRNewswire/ -- Precision diagnostics company BillionToOne is addressing the longstanding challenges pregnant women face in remote areas. The company's UNITY ...
https://www.prnewswire.com/news-releases/billiontoones-unity-fetal-antigen-nipt-transforms-care-in-maternity-health-deserts-302336652.htmlBillionToOneCalifornia tech company BillionToOne plans new campus in Texas
Texas keeps raking in the tech companies, and the Lone Star State is adding another entity to its growing list of California startups with the expansion of ...
https://www.msn.com/en-us/money/companies/california-tech-company-billiontoone-plans-new-campus-in-texas/ar-AA1rgxBxBillionToOneBillionToOne to expand in Austin - Austin Business Journal
Silicon Valley-based cancer test developer BillionToOne was valued at $1 billion in a December funding round. Shown here are co-founders Oguzhan Atay and David ...
https://www.bizjournals.com/austin/news/2024/09/11/billiontoone-set-to-open-forever-lab-in-austin.htmlBillionToOneCategory Defining Molecular Diagnostics Company BillionToOne ...
Category Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with ...
http://www.streetinsider.com/Press+Releases/Category+Defining+Molecular+Diagnostics+Company+BillionToOne+Further+Solidifies+its+Long-Term+Position+by+Securing+%24140+Million+Non-Dilutive+Financing+with+Oberland+Capital/23684625.htmlBillionToOneBillionToOne Adopting Semaphore Solutions' Labbit LIMS in its ...
BillionToOne is implementing Semaphore's Laboratory Information Management System (LIMS), Labbit, in their oncology laboratories in preparation for significant ...
https://www.msn.com/en-us/health/other/billiontoone-adopting-semaphore-solutions-labbit-lims-in-its-precision-oncology-diagnostics-laboratories/ar-AA1pYlD7
Show more (3)Investors3
Baillie Gifford
Y Combinator
Norwest Venture Partners